The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The global Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vaccine in various end use industries. The expanding demands from the For Adult and For Child, are propelling Vaccine market. Varicella Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Influenza Vaccine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Vaccine market, driven by demand from China, the second largest economy with some signs of stabilising, the Vaccine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccine covered in this report include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK and Hulan Bio, etc.
The global Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Global Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine market, Segment by Type:
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Global Vaccine market, by Application
For Adult
For Child
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The global Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vaccine in various end use industries. The expanding demands from the For Adult and For Child, are propelling Vaccine market. Varicella Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Influenza Vaccine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Vaccine market, driven by demand from China, the second largest economy with some signs of stabilising, the Vaccine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccine covered in this report include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK and Hulan Bio, etc.
The global Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Global Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine market, Segment by Type:
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Global Vaccine market, by Application
For Adult
For Child
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Vaccine
1.1 Vaccine Market Overview
1.1.1 Vaccine Product Scope
1.1.2 Vaccine Market Status and Outlook
1.2 Global Vaccine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Vaccine Market Size by Region (2018-2029)
1.4 Global Vaccine Historic Market Size by Region (2018-2023)
1.5 Global Vaccine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Vaccine Market Size (2018-2029)
1.6.1 North America Vaccine Market Size (2018-2029)
1.6.2 Europe Vaccine Market Size (2018-2029)
1.6.3 Asia-Pacific Vaccine Market Size (2018-2029)
1.6.4 Latin America Vaccine Market Size (2018-2029)
1.6.5 Middle East & Africa Vaccine Market Size (2018-2029)
2 Vaccine Market by Type
2.1 Introduction
2.1.1 Varicella Vaccine
2.1.2 Influenza Vaccine
2.1.3 Polio Vaccine
2.1.4 Hepatitis A Vaccine
2.1.5 Rabies Vaccine
2.1.6 BCG Vaccine
2.1.7 Hepatitis B
2.1.8 Pertussis, Diphtheria, Tetanus
2.1.9 Pneumococcal
2.1.10 Others
2.2 Global Vaccine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Vaccine Historic Market Size by Type (2018-2023)
2.2.2 Global Vaccine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Vaccine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Vaccine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Vaccine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Vaccine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Vaccine Revenue Breakdown by Type (2018-2029)
3 Vaccine Market Overview by Application
3.1 Introduction
3.1.1 For Adult
3.1.2 For Child
3.2 Global Vaccine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Vaccine Historic Market Size by Application (2018-2023)
3.2.2 Global Vaccine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Vaccine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Vaccine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Vaccine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Vaccine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Vaccine Revenue Breakdown by Application (2018-2029)
4 Vaccine Competition Analysis by Players
4.1 Global Vaccine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine as of 2022)
4.3 Date of Key Players Enter into Vaccine Market
4.4 Global Top Players Vaccine Headquarters and Area Served
4.5 Key Players Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Profile
5.1.2 AstraZeneca Main Business
5.1.3 AstraZeneca Vaccine Products, Services and Solutions
5.1.4 AstraZeneca Vaccine Revenue (US$ Million) & (2018-2023)
5.1.5 AstraZeneca Recent Developments
5.2 BioNTech
5.2.1 BioNTech Profile
5.2.2 BioNTech Main Business
5.2.3 BioNTech Vaccine Products, Services and Solutions
5.2.4 BioNTech Vaccine Revenue (US$ Million) & (2018-2023)
5.2.5 BioNTech Recent Developments
5.3 Boehringer-Ingelheim
5.3.1 Boehringer-Ingelheim Profile
5.3.2 Boehringer-Ingelheim Main Business
5.3.3 Boehringer-Ingelheim Vaccine Products, Services and Solutions
5.3.4 Boehringer-Ingelheim Vaccine Revenue (US$ Million) & (2018-2023)
5.3.5 CCBIO Recent Developments
5.4 CCBIO
5.4.1 CCBIO Profile
5.4.2 CCBIO Main Business
5.4.3 CCBIO Vaccine Products, Services and Solutions
5.4.4 CCBIO Vaccine Revenue (US$ Million) & (2018-2023)
5.4.5 CCBIO Recent Developments
5.5 CSL
5.5.1 CSL Profile
5.5.2 CSL Main Business
5.5.3 CSL Vaccine Products, Services and Solutions
5.5.4 CSL Vaccine Revenue (US$ Million) & (2018-2023)
5.5.5 CSL Recent Developments
5.6 CureVac
5.6.1 CureVac Profile
5.6.2 CureVac Main Business
5.6.3 CureVac Vaccine Products, Services and Solutions
5.6.4 CureVac Vaccine Revenue (US$ Million) & (2018-2023)
5.6.5 CureVac Recent Developments
5.7 Elanco
5.7.1 Elanco Profile
5.7.2 Elanco Main Business
5.7.3 Elanco Vaccine Products, Services and Solutions
5.7.4 Elanco Vaccine Revenue (US$ Million) & (2018-2023)
5.7.5 Elanco Recent Developments
5.8 GSK
5.8.1 GSK Profile
5.8.2 GSK Main Business
5.8.3 GSK Vaccine Products, Services and Solutions
5.8.4 GSK Vaccine Revenue (US$ Million) & (2018-2023)
5.8.5 GSK Recent Developments
5.9 Hulan Bio
5.9.1 Hulan Bio Profile
5.9.2 Hulan Bio Main Business
5.9.3 Hulan Bio Vaccine Products, Services and Solutions
5.9.4 Hulan Bio Vaccine Revenue (US$ Million) & (2018-2023)
5.9.5 Hulan Bio Recent Developments
5.10 Indian Immunologicals
5.10.1 Indian Immunologicals Profile
5.10.2 Indian Immunologicals Main Business
5.10.3 Indian Immunologicals Vaccine Products, Services and Solutions
5.10.4 Indian Immunologicals Vaccine Revenue (US$ Million) & (2018-2023)
5.10.5 Indian Immunologicals Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Vaccine Products, Services and Solutions
5.11.4 Merck Vaccine Revenue (US$ Million) & (2018-2023)
5.11.5 Merck Recent Developments
5.12 Minhai Biotechnology
5.12.1 Minhai Biotechnology Profile
5.12.2 Minhai Biotechnology Main Business
5.12.3 Minhai Biotechnology Vaccine Products, Services and Solutions
5.12.4 Minhai Biotechnology Vaccine Revenue (US$ Million) & (2018-2023)
5.12.5 Minhai Biotechnology Recent Developments
5.13 Mitsubishi Tanabe Pharma
5.13.1 Mitsubishi Tanabe Pharma Profile
5.13.2 Mitsubishi Tanabe Pharma Main Business
5.13.3 Mitsubishi Tanabe Pharma Vaccine Products, Services and Solutions
5.13.4 Mitsubishi Tanabe Pharma Vaccine Revenue (US$ Million) & (2018-2023)
5.13.5 Mitsubishi Tanabe Pharma Recent Developments
5.14 Moderna Therapeutics
5.14.1 Moderna Therapeutics Profile
5.14.2 Moderna Therapeutics Main Business
5.14.3 Moderna Therapeutics Vaccine Products, Services and Solutions
5.14.4 Moderna Therapeutics Vaccine Revenue (US$ Million) & (2018-2023)
5.14.5 Moderna Therapeutics Recent Developments
5.15 Mylan
5.15.1 Mylan Profile
5.15.2 Mylan Main Business
5.15.3 Mylan Vaccine Products, Services and Solutions
5.15.4 Mylan Vaccine Revenue (US$ Million) & (2018-2023)
5.15.5 Mylan Recent Developments
5.16 Plumbline Life Sciences
5.16.1 Plumbline Life Sciences Profile
5.16.2 Plumbline Life Sciences Main Business
5.16.3 Plumbline Life Sciences Vaccine Products, Services and Solutions
5.16.4 Plumbline Life Sciences Vaccine Revenue (US$ Million) & (2018-2023)
5.16.5 Plumbline Life Sciences Recent Developments
5.17 Sanofi
5.17.1 Sanofi Profile
5.17.2 Sanofi Main Business
5.17.3 Sanofi Vaccine Products, Services and Solutions
5.17.4 Sanofi Vaccine Revenue (US$ Million) & (2018-2023)
5.17.5 Sanofi Recent Developments
5.18 Translate Bio
5.18.1 Translate Bio Profile
5.18.2 Translate Bio Main Business
5.18.3 Translate Bio Vaccine Products, Services and Solutions
5.18.4 Translate Bio Vaccine Revenue (US$ Million) & (2018-2023)
5.18.5 Translate Bio Recent Developments
5.19 Walvax Biotechnology
5.19.1 Walvax Biotechnology Profile
5.19.2 Walvax Biotechnology Main Business
5.19.3 Walvax Biotechnology Vaccine Products, Services and Solutions
5.19.4 Walvax Biotechnology Vaccine Revenue (US$ Million) & (2018-2023)
5.19.5 Walvax Biotechnology Recent Developments
5.20 Wuhan Institute of Biological Products
5.20.1 Wuhan Institute of Biological Products Profile
5.20.2 Wuhan Institute of Biological Products Main Business
5.20.3 Wuhan Institute of Biological Products Vaccine Products, Services and Solutions
5.20.4 Wuhan Institute of Biological Products Vaccine Revenue (US$ Million) & (2018-2023)
5.20.5 Wuhan Institute of Biological Products Recent Developments
5.21 Zoties
5.21.1 Zoties Profile
5.21.2 Zoties Main Business
5.21.3 Zoties Vaccine Products, Services and Solutions
5.21.4 Zoties Vaccine Revenue (US$ Million) & (2018-2023)
5.21.5 Zoties Recent Developments
6 North America
6.1 North America Vaccine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Vaccine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Vaccine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Vaccine Market Dynamics
11.1 Vaccine Industry Trends
11.2 Vaccine Market Drivers
11.3 Vaccine Market Challenges
11.4 Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
